chr1-171203866-T-C
Variant summary
Our verdict is Uncertain significance. Variant got 4 ACMG points: 4P and 0B. PM2PP3_Moderate
The NM_001460.5(FMO2):āc.629T>Cā(p.Val210Ala) variant causes a missense, splice region change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000186 in 1,613,300 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_001460.5 missense, splice_region
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 4 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
FMO2 | NM_001460.5 | c.629T>C | p.Val210Ala | missense_variant, splice_region_variant | 6/9 | ENST00000209929.10 | NP_001451.2 | |
LOC124900413 | XR_007066731.1 | n.366-6928A>G | intron_variant, non_coding_transcript_variant | |||||
LOC105371611 | XR_922278.4 | n.515-35678A>G | intron_variant, non_coding_transcript_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
FMO2 | ENST00000209929.10 | c.629T>C | p.Val210Ala | missense_variant, splice_region_variant | 6/9 | 1 | NM_001460.5 | ENSP00000209929 | P1 | |
ENST00000445290.1 | n.139-4351A>G | intron_variant, non_coding_transcript_variant | 2 | |||||||
ENST00000669750.1 | n.449-35678A>G | intron_variant, non_coding_transcript_variant |
Frequencies
GnomAD3 genomes AF: 0.0000788 AC: 12AN: 152194Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000200 AC: 5AN: 250356Hom.: 0 AF XY: 0.0000222 AC XY: 3AN XY: 135290
GnomAD4 exome AF: 0.0000110 AC: 16AN: 1460988Hom.: 0 Cov.: 31 AF XY: 0.00000963 AC XY: 7AN XY: 726828
GnomAD4 genome AF: 0.0000919 AC: 14AN: 152312Hom.: 0 Cov.: 32 AF XY: 0.0000940 AC XY: 7AN XY: 74476
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 24, 2022 | The c.629T>C (p.V210A) alteration is located in exon 6 (coding exon 5) of the FMO2 gene. This alteration results from a T to C substitution at nucleotide position 629, causing the valine (V) at amino acid position 210 to be replaced by an alanine (A). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at